Why Hercules Offshore, Merrimack Pharmaceuticals, and Smith & Wesson Holdings Tumbled Today

Continued signs of strength in the U.S. economy kept investors in a good mood Friday, with major stock market indexes hitting new all-time records while the Nasdaq Composite (NASDAQINDEX: ^IXIC  ) reached its best level in 14 years since the end of the tech boom. In general, positive news from several individual companies helped boost the overall tone of the market, but some exceptions held stocks back from more substantial gains. Among them were Hercules Offshore (NASDAQOTH: HERO  ) , Merrimack Pharmaceuticals (NASDAQ: MACK  ) , and Smith & Wesson Holdings (NASDAQ: SWHC  ) , which were among the worst performers in the stock market today.

Hercules Offshore fell 12% as the drilling specialist chose to give up on a potentially lucrative contract for a rig off the coast of the African country of Angola. Angola has been a hotbed of energy activity lately, and investors were disappointed that Hercules couldn't come up with ways of getting past a roadblock that had held up the project's approval. Given the competitive disadvantage Hercules Offshore has suffered compared to rivals that are more focused on the more promising deepwater and ultra-deepwater opportunities for drilling companies, shareholders were obviously sensitive to any failure on Hercules Offshore's part to make the most of the changes it does have to earn profits.

Merrimack Pharmaceuticals declined 11% after the cancer-treatment developer said that it would take back full control of its global rights from Sanofi to work on and sell its MM-121 monoclonal-antibody based cancer treatment candidate. Merrimack has had mixed success with MM-121, with clinical data not supporting positive outcomes in ovarian cancer and more recent data in a breast-cancer trial showing a greater incidence of adverse events. With its partner essentially backing out, Merrimack will have to convince shareholders that the treatment still has solid potential.

Source: Smith & Wesson.

Smith & Wesson Holdings gave up 9% after its fiscal fourth-quarter earnings report last night, which included troubling guidance suggesting falling gun sales. Backward-looking results looked strong, with both revenue and earnings faring better than most investors had thought. But projections for current-quarter and full fiscal year revenue were far lower than projected, scaring many investors. Smart long-term investors are aware that Smith & Wesson has anticipated this trend for a long time, and the bigger question is whether the company can steal away market share from other gun manufacturers and strengthen its position within the industry. If so, then today's sell-off could bring a long-term opportunity for those willing to take the risk.

Top dividend stocks for the next decade
The smartest investors know that dividend stocks simply crush their non-dividend-paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3002843, ~/Articles/ArticleHandler.aspx, 9/3/2015 5:05:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Caplinger

Dan Caplinger has been a contract writer for the Motley Fool since 2006. As the Fool's Director of Investment Planning, Dan oversees much of the personal-finance and investment-planning content published daily on With a background as an estate-planning attorney and independent financial consultant, Dan's articles are based on more than 20 years of experience from all angles of the financial world.

Today's Market

updated 7 hours ago Sponsored by:
DOW 16,351.38 293.03 1.82%
S&P 500 1,948.86 35.01 1.83%
NASD 4,749.98 113.87 2.46%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/2/2015 5:15 PM
^IXIC $4749.98 Up +113.87 +2.46%
NASDAQ Composite… CAPS Rating: No stars
HERO $0.00 Down +0.00 +0.00%
Hercules Offshore,… CAPS Rating: **
MACK $10.15 Up +0.62 +6.51%
Merrimack Pharmace… CAPS Rating: ***
SWHC $18.34 Down -0.04 -0.22%
Smith & Wesson Hol… CAPS Rating: ***